PRF1 and lung cancer: Moreover, lung cancer-derived EVs are enriched with circUSP7 to attenuate granzyme B and perforin secretion by CD8 + T cells, thereby facilitating lung cancer resistance to anti-PD-1 immunotherapy [99].